|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Structure of pka-pkb chimera complexed with c-(4-(4-chlorophenyl)-1- (7h-pyrrolo(2,3-d)pyrimidin-4-yl)piperidin-4-yl)methylamine
|
|
Structure:
|
 |
Camp-dependent protein kinase, alpha-catalytic subunitprote. Chain: a. Synonym: protein kinase a, pka c-alpha. Engineered: yes. Mutation: yes. Camp-dependent protein kinase inhibitor alpha. Chain: i. Fragment: residues 6-25.
|
|
Source:
|
 |
Bos taurus. Bovine. Organism_taxid: 9913. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Homo sapiens. Human. Organism_taxid: 9606
|
|
Resolution:
|
 |
|
1.94Å
|
R-factor:
|
0.165
|
R-free:
|
0.216
|
|
|
Authors:
|
 |
J.J.Caldwell,T.G.Davies,A.Donald,T.Mchardy,M.G.Rowlands,G.W.Aherne, L.K.Hunter,K.Taylor,R.Ruddle,F.I.Raynaud,M.Verdonk,P.Workman, M.D.Garrett,I.Collins
|
|
Key ref:
|
 |
J.J.Caldwell
et al.
(2008).
Identification of 4-(4-aminopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration.
J Med Chem,
51,
2147-2157.
PubMed id:
|
 |
|
Date:
|
 |
|
08-Feb-08
|
Release date:
|
08-Apr-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain A:
E.C.2.7.11.11
- cAMP-dependent protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
J Med Chem
51:2147-2157
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Identification of 4-(4-aminopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration.
|
|
J.J.Caldwell,
T.G.Davies,
A.Donald,
T.McHardy,
M.G.Rowlands,
G.W.Aherne,
L.K.Hunter,
K.Taylor,
R.Ruddle,
F.I.Raynaud,
M.Verdonk,
P.Workman,
M.D.Garrett,
I.Collins.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Fragment-based screening identified 7-azaindole as a protein kinase B inhibitor
scaffold. Fragment elaboration using iterative crystallography of
inhibitor-PKA-PKB chimera complexes efficiently guided improvements in the
potency and selectivity of the compounds, resulting in the identification of
nanomolar 6-(piperidin-1-yl)purine, 4-(piperidin-1-yl)-7-azaindole, and
4-(piperidin-1-yl)pyrrolo[2,3- d]pyrimidine inhibitors of PKBbeta with
antiproliferative activity and showing pathway inhibition in cells. A divergence
in the binding mode was seen between 4-aminomethylpiperidine and
4-aminopiperidine containing molecules. Selectivity for PKB vs PKA was observed
with 4-aminopiperidine derivatives, and the most PKB-selective inhibitor
(30-fold) showed significantly different bound conformations between PKA and
PKA-PKB chimera.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
R.Xu,
A.Banka,
J.F.Blake,
I.S.Mitchell,
E.M.Wallace,
J.R.Bencsik,
N.C.Kallan,
K.L.Spencer,
S.L.Gloor,
M.Martinson,
T.Risom,
S.D.Gross,
T.H.Morales,
W.I.Wu,
G.P.Vigers,
B.J.Brandhuber,
and
N.J.Skelton
(2011).
Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA.
|
| |
Bioorg Med Chem Lett,
21,
2335-2340.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.W.Murray,
and
T.L.Blundell
(2010).
Structural biology in fragment-based drug design.
|
| |
Curr Opin Struct Biol,
20,
497-507.
|
 |
|
|
|
|
 |
T.McHardy,
J.J.Caldwell,
K.M.Cheung,
L.J.Hunter,
K.Taylor,
M.Rowlands,
R.Ruddle,
A.Henley,
A.de Haven Brandon,
M.Valenti,
T.G.Davies,
L.Fazal,
L.Seavers,
F.I.Raynaud,
S.A.Eccles,
G.W.Aherne,
M.D.Garrett,
and
I.Collins
(2010).
Discovery of 4-amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides as selective, orally active inhibitors of protein kinase B (Akt).
|
| |
J Med Chem,
53,
2239-2249.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
X.Zhang,
A.C.Gibbs,
C.H.Reynolds,
M.B.Peters,
and
L.M.Westerhoff
(2010).
Quantum mechanical pairwise decomposition analysis of protein kinase B inhibitors: validating a new tool for guiding drug design.
|
| |
J Chem Inf Model,
50,
651-661.
|
 |
|
|
|
|
 |
C.O.Kappe,
and
D.Dallinger
(2009).
Controlled microwave heating in modern organic synthesis: highlights from the 2004-2008 literature.
|
| |
Mol Divers,
13,
71.
|
 |
|
|
|
|
 |
G.E.de Kloe,
D.Bailey,
R.Leurs,
and
I.J.de Esch
(2009).
Transforming fragments into candidates: small becomes big in medicinal chemistry.
|
| |
Drug Discov Today,
14,
630-646.
|
 |
|
|
|
|
 |
L.A.Smyth,
and
I.Collins
(2009).
Measuring and interpreting the selectivity of protein kinase inhibitors.
|
| |
J Chem Biol,
2,
131-151.
|
 |
|
|
|
|
 |
R.Badorrey,
E.Portaña,
M.D.Díaz-de-Villegas,
and
J.A.Gálvez
(2009).
Stereocontrolled synthesis of orthogonally protected 2-substituted 4-aminopiperidines.
|
| |
Org Biomol Chem,
7,
2912-2918.
|
 |
|
|
|
|
 |
R.L.van Montfort,
and
P.Workman
(2009).
Structure-based design of molecular cancer therapeutics.
|
| |
Trends Biotechnol,
27,
315-328.
|
 |
|
|
|
|
 |
X.Yang,
Q.Shi,
Y.N.Liu,
G.Zhao,
K.F.Bastow,
J.C.Lin,
S.C.Yang,
P.C.Yang,
and
K.H.Lee
(2009).
Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agents.
|
| |
J Med Chem,
52,
5262-5268.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |